Nissen Fundoplication utilizing the Senhance™ Surgical System.
In the EU: Senhance™ is CE marked according to the MDD and is intended to be used for laparoscopic surgery in the abdomen, pelvis and limited uses in the thoracic cavity excluding the heart and greater vessels of adults. The device is restricted to sale by or on the order of a physician.
TransEnterix Italy is the legal manufacturer for CE purposes.
Products may not be available in all markets and indications for use vary by region. Please visit www.transenterix.com/indications-for-use or contact your local representative for information about your area.
Senhance was developed under a license of the European Commission Joint Research Centre.
© 2019 TransEnterix Surgical, Inc. All rights reserved.
Senhance is a trademark of TransEnterix Surgical, Inc.
Brand and product names are trademarks or registered trademarks of their respective holders.